Phosphoinositide-Dependent Kinase 1 and mTORC2 Synergistically Maintain Postnatal Heart Growth and Heart Function in Mice

REFERENCES

• Braunwald E. 2013. Cardiovascular science: opportunities for translating research into improved care. J. Clin. Invest. 123:6–10. http://dx.doi.org/10.1172/JCI67541.
   PubMedGoogle Scholar
• McNally EM, Golbus JR, Puckelwartz MJ. 2013. Genetic mutations and mechanisms in dilated cardiomyopathy. J. Clin. Invest. 123:19–26. http://dx.doi.org/10.1172/JCI62862.
   PubMedGoogle Scholar
• Hershberger RE, Morales A, Siegfried JD. 2010. Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genet. Med. 12:655–667. http://dx.doi.org/10.1097/GIM.0b013e3181f2481f.
   PubMed Web of Science ®Google Scholar
• Jefferies JL, Towbin JA. 2010. Dilated cardiomyopathy. Lancet 375:752–762. http://dx.doi.org/10.1016/S0140-6736(09)62023-7.
   PubMed Web of Science ®Google Scholar
• Olson EN, Schneider MD. 2003. Sizing up the heart: development redux in disease. Genes Dev. 17:1937–1956. http://dx.doi.org/10.1101/gad.1110103.
   PubMed Web of Science ®Google Scholar
• Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541.
   PubMed Web of Science ®Google Scholar
• Alessi DR, Deak M, Casamayor A, Barry Caudwell F, Morrice N, Norman DG, Gaffney P, Reese CB, MacDougall CN, Harbison D. 1997. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7:776–789. http://dx.doi.org/10.1016/S0960-9822(06)00336-8.
   PubMed Web of Science ®Google Scholar
• Brazil D, Yang Z, Hemmings B. 2004. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29:233–242. http://dx.doi.org/10.1016/j.tibs.2004.03.006.
   PubMed Web of Science ®Google Scholar
• Chang Z, Xiao Q, Feng Q, Yang Z. 2010. PKB/Akt signaling in heart development and disease. Front. Biosci. 2:1485–1491. http://dx.doi.org/10.2741/E207.
   Google Scholar
• Mora AKD, van Aalten DM, Alessi DR. 2004. PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 15:161–170. http://dx.doi.org/10.1016/j.semcdb.2003.12.022.
   PubMed Web of Science ®Google Scholar
• Guertin DA, Sabatini DM. 2009. The pharmacology of mTOR inhibition. Sci. Signal. 2:24. http://dx.doi.org/10.1126/scisignal.267pe24.
   Web of Science ®Google Scholar
• Polak P, Hall M. 2009. mTOR and the control of whole body metabolism. Curr. Opin. Cell Biol. 21:209–218. http://dx.doi.org/10.1016/j.ceb.2009.01.024.
   PubMed Web of Science ®Google Scholar
• Sarbassov D, Guertin D, Ali S, Sabatini D. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098–1101. http://dx.doi.org/10.1126/science.1106148.
   PubMed Web of Science ®Google Scholar
• Williams MR, Arthur JSC, Balendran A, van der Kaay J, Poli V, Cohen P, Alessi DR. 2000. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10:439–448. http://dx.doi.org/10.1016/S0960-9822(00)00441-3.
   PubMed Web of Science ®Google Scholar
• Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, Brown M, Fitzgerald KJ, Sabatini DM. 2006. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKC [alpha], but not S6K1. Dev. Cell 11:859–871. http://dx.doi.org/10.1016/j.devcel.2006.10.007.
   PubMed Web of Science ®Google Scholar
• Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY, Huang Q, Qin J, Su B. 2006. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127:125–137. http://dx.doi.org/10.1016/j.cell.2006.08.033.
   PubMed Web of Science ®Google Scholar
• Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, Bonenfant D, Oppliger W, Jenoe P, Hall MN. 2002. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10:457–468. http://dx.doi.org/10.1016/S1097-2765(02)00636-6.
   PubMed Web of Science ®Google Scholar
• Zhang D, Contu R, Latronico MVG, Zhang J, Rizzi R, Catalucci D, Miyamoto S, Huang K, Ceci M, Gu Y, Dalton ND, Peterson KL, Guan KL, Brown JH, Chen J, Sonenberg N, Condorelli G. 2010. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J. Clin. Invest. 120:2805–2816. http://dx.doi.org/10.1172/JCI43008.
   PubMed Web of Science ®Google Scholar
• Xie X, Zhang D, Zhao B, Lu M-K, You M, Condorelli G, Wang C-Y, Guan K-L. 2011. IκB kinase ε and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 108:6474–6479. http://dx.doi.org/10.1073/pnas.1016132108.
   PubMed Web of Science ®Google Scholar
• Di R, Wu X, Chang Z, Zhao X, Feng Q, Lu S, Luan Q, Hemmings B, Li X, Yang Z. 2012. S6K inhibition renders cardiac protection against myocardial infarction through PDK1 phosphorylation of Akt. Biochem. J. 441:199–207. http://dx.doi.org/10.1042/BJ20110033.
   PubMed Web of Science ®Google Scholar
• He W, Peng Y, Zhang W, Lv N, Tang J, Chen C, Zhang C, Gao S, Chen H, Zhi G. 2008. Myosin light chain kinase is central to smooth muscle contraction and required for gastrointestinal motility in mice. Gastroenterology 135:610–620. http://dx.doi.org/10.1053/j.gastro.2008.05.032.
   PubMed Web of Science ®Google Scholar
• Yang Z, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, Perentes E, Hemmings B. 2003. Protein kinase Bα/Akt 1 regulates placental development and fetal growth. J. Biol. Chem. 278:32124–32131. http://dx.doi.org/10.1074/jbc.M302847200.
   PubMed Web of Science ®Google Scholar
• Feng Q, Di R, Tao F, Chang Z, Lu S, Fan W, Shan C, Li X, Yang Z. 2010. PDK1 regulates vascular remodeling and promotes epithelial-mesenchymal transition in cardiac development. Mol. Cell. Biol. 30:3711–3721. http://dx.doi.org/10.1128/MCB.00420-10.
   PubMedGoogle Scholar
• Mora A, Davies A, Bertrand L, Sharif I, Budas G, Jovanovi S, Mouton V, Kahn C, Lucocq J, Gray G, Jovanović A, Alessi D. 2003. Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. EMBO J. 22:4666–4676. http://dx.doi.org/10.1093/emboj/cdg469.
   PubMed Web of Science ®Google Scholar
• Shiota C, Woo JT, Lindner J, Shelton KD, Magnuson MA. 2006. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev. Cell 11:583–589. http://dx.doi.org/10.1016/j.devcel.2006.08.013.
   PubMed Web of Science ®Google Scholar
• Yang Z, Tschopp O, Di-Poi N, Bruder E, Baudry A, Dummler B, Wahli W, Hemmings B. 2005. Dosage-dependent effects of Akt1/protein kinase Bα(PKBα) and Akt3/PKBγ on thymus, skin, and cardiovascular and nervous system development in mice. Mol. Cell. Biol. 25:10407–10418. http://dx.doi.org/10.1128/MCB.25.23.10407-10418.2005.
   PubMed Web of Science ®Google Scholar
• Chang Z, Zhang Q, Feng Q, Xu J, Teng T, Luan Q, Shan C, Hu Y, Hemmings BA, Gao X, Yang Z. 2010. Deletion of Akt1 causes heart defects and abnormal cardiomyocyte proliferation. Dev. Biol. 347:384–391. http://dx.doi.org/10.1016/j.ydbio.2010.08.033.
   PubMedGoogle Scholar
• Bentzinger CF, Romanino K, Cloetta D, Lin S, Mascarenhas JB, Oliveri F, Xia J, Casanova E, Costa CF, Brink M, Zorzato F, Hall MN, Ruegg MA. 2008. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 8:411–424. http://dx.doi.org/10.1016/j.cmet.2008.10.002.
   PubMed Web of Science ®Google Scholar
• Cybulski N, Polak P, Auwerx J, Ruegg MA, Hall MN. 2009. mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc. Natl. Acad. Sci. U. S. A. 106:9902–9907. http://dx.doi.org/10.1073/pnas.0811321106.
   PubMed Web of Science ®Google Scholar
• Lazorchak AS, Liu D, Facchinetti V, Di Lorenzo A, Sessa WC, Schatz DG, Su B. 2010. Sin1-mTORC2 SUppresses rag and il7r gene expression through Akt2 in B cells. Mol. Cell 3:433–443. http://dx.doi.org/10.1016/j.molcel.2010.07.031.
   Google Scholar
• Oudit GY, Kassiri Z, Zhou J, Liu QC, Liu PP, Backx PH, Dawood F, Crackower MA, Scholey JW, Penninger JM. 2008. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. Cardiovasc. Res. 78:505–514. http://dx.doi.org/10.1093/cvr/cvn041.
   PubMed Web of Science ®Google Scholar
• Ruan H, Li J, Ren S, Gao J, Li G, Kim R, Wu H, Wang Y. 2009. Inducible and cardiac specific PTEN inactivation protects ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 46:193–200. http://dx.doi.org/10.1016/j.yjmcc.2008.10.021.
   PubMed Web of Science ®Google Scholar
• Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29–39. http://dx.doi.org/10.1016/S0092-8674(00)81780-8.
   PubMed Web of Science ®Google Scholar
• Keyes KT, Xu J, Long B, Zhang C, Hu Z, Ye Y. 2010. Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction. Am. J. Physiol. Heart Circ. Physiol. 298:H1198–H1208. http://dx.doi.org/10.1152/ajpheart.00915.2009.
   PubMedGoogle Scholar
• Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098. http://dx.doi.org/10.1126/science.1106148.
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, Markhard AL, Sabatini DM. 2006. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22:159–168. http://dx.doi.org/10.1016/j.molcel.2006.03.029.
   PubMed Web of Science ®Google Scholar
• Bertrand L, Horman S, Beauloye C, Vanoverschelde JL. 2008. Insulin signalling in the heart. Cardiovasc. Res. 79:238–248. http://dx.doi.org/10.1093/cvr/cvn093.
   PubMed Web of Science ®Google Scholar
• Feng J, Park J, Cron P, Hess D, Hemmings BA. 2004. Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J. Biol. Chem. 279:41189. http://dx.doi.org/10.1074/jbc.M406731200.
   PubMed Web of Science ®Google Scholar
• White DE, Coutu P, Shi Y-F, Tardif J-C, Nattel S, St Arnaud R, Dedhar S, Muller WJ. 2006. Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev. 20:2355–2360. http://dx.doi.org/10.1101/gad.1458906.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Pires KM, Whitehead KJ, Olsen CD, Wayment B, Zhang YC, Bugger H, Ilkun O, Litwin SE, Thomas G. 2013. Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth. PLoS One 8:e54221. http://dx.doi.org/10.1371/journal.pone.0054221.
   PubMed Web of Science ®Google Scholar
• Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G. 2004. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431:200–205. http://dx.doi.org/10.1038/nature02866.
   PubMed Web of Science ®Google Scholar
• Cairns RA, Harris IS, Mak TW. 2011. Regulation of cancer cell metabolism. Nat. Rev. Cancer 11:85–95. http://dx.doi.org/10.1038/nrc2981.
   PubMed Web of Science ®Google Scholar
• Haq S, Choukroun G, Lim H, Tymitz KM, del Monte F, Gwathmey J, Grazette L, Michael A, Hajjar R, Force T, Molkentin JD. 2001. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103:670–677. http://dx.doi.org/10.1161/01.CIR.103.5.670.
   PubMed Web of Science ®Google Scholar
• Nagoshi T, Matsui T, Aoyama T, Leri A, Anversa P, Li L, Ogawa W, del Monte F, Gwathmey JK, Grazette L, Hemmings B, Kass DA, Champion HC, Rosenzweig A. 2005. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J. Clin. Invest. 115:2128–2138. http://dx.doi.org/10.1172/JCI23073.
   PubMed Web of Science ®Google Scholar
• Ito K, Akazawa H, Tamagawa M, Furukawa K, Ogawa W, Yasuda N, Kudo Y, Liao C, Yamamoto R, Sato T. 2009. PDK1 coordinates survival pathways and β-adrenergic response in the heart. Proc. Natl. Acad. Sci. U. S. A. 106:8689. http://dx.doi.org/10.1073/pnas.0900064106.
   PubMedGoogle Scholar
• Alfonso Mora AMD, Luc Bertrand IS, Grant RB. 2003. Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. EMBO J. 22:4666–4676. http://dx.doi.org/10.1093/emboj/cdg469.
   PubMedGoogle Scholar